-------------------- The difference between genius and stupidity is that genius has its limits Posts: 10204 | From: NYC | Registered: Mar 2006
| IP: Logged |
posted
Biogenerics Announces Share Dividend Ratio From WW Oil and Gas Inc. TYLER, Texas, Dec. 22, 2006 (PRIME NEWSWIRE) -- Biogenerics Limited (Pink Sheets:BIGN) announced that its shareholders of record as of January 2, 2007 will receive 1(one) WW Oil and Gas Inc. restricted common share for every 19(nineteen) Biogenerics shares held. The shares will be paid out on January 30, 2007. The special dividend shares will be mailed out to qualified shareholders of record without any action(s) required by eligible recipients.
Website: http:/www.bignltd.com
About Biogenerics Limited
Biogenerics is a diversified investment venture capital firm focused on exploiting and distributing domestic oil and gas reserves. Biogenerics also has joint venture activities with Tyche Energy Inc and Hydroslotter Corp.
WW Oil & Gas Inc., established in 2005, is in the business of acquiring leases and oil and gas related assets. Such acquisitions are for the purposes of development, exploration, and exploitation. The company currently has several exploitation projects encompassing four oil and gas leases in the San Juan Basin area of New Mexico and Oklahoma. Comprehensive drill programs are being developed for full exploitation of these projects. ConocoPhillips, XTO Energy and British Petroleum are among those companies active in the San Juan Basin.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this release that are forward-looking statements are based on current expectations and assumptions that are subject to known and unknown risks, uncertainties, or other factors which may cause actual results, performance, or achievements of the company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Actual results could differ materially because of factors such as the effect of general economic and market conditions, entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, technological shifts, and delays in product development and related product release schedules, any of which may cause revenues and income to fall short of anticipated levels. All information in this release is as of the date of this release. The company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company's expectations.
CONTACT: Biogenerics Limited Corporate Inquiries James Lancaster, CEO (903)-561-2446 Investor Relations www.bignltd.com
-------------------- The difference between genius and stupidity is that genius has its limits Posts: 10204 | From: NYC | Registered: Mar 2006
| IP: Logged |
And with that oil Divi coming this first week in Jan it just may keep going up like a rocket!
[from above] ...that its shareholders of record as of January 2, 2007 will receive 1(one) WW Oil and Gas Inc. restricted common share for every 19(nineteen) Biogenerics shares held. The shares will be paid out on January 30, 2007.
posted
BIGN .014 Biogenerics Provides Update on East Texas LOI and Grimes
TYLER, Texas, Jan 11, 2007 (*********wire via COMTEX) -- Biogenerics Limited (Pink Sheets:BIGN) is pleased to update shareholders on the company's progress which is as follows:
East Texas Joint Venture Transaction: The Board of Directors is happy to announce that the East Texas Oil Field Joint Venture Transaction is still proceeding. The delay is due to the fact that currently, the transaction has now escalated to involve 2,714 acres of leases, over 300 wells with production projected to be over 15,000 bbls/oil/month within the first six months of the expected conclusion. Part of this transaction will include future well sites for offset drilling production on the current leases involving the Lower Stringer and Main Woodbine/Ashe Stringer zones.
Steps have been taken to complete initial field due diligence and obtain commitments from key employees for continued services. Currently, the Joint Venture Participants are working diligently to conclude the clearing of titles on all leases including all necessary State of Texas operator requirements. Management is examining and observing active well operations to determine future production capacities. In conjunction with this, an existing active well, which was producing 3 bbls/oil/day, was re-completed at the lower pay zone and is now producing over 45 bbls/day, increasing production by over 1,200 bbls/oil/month. This test of increased production capacity verified the Joint Venture Participant's projections in its financial model. The Company expects that this transaction will reach a viable conclusion within the first quarter of this calendar year. Management continues to pursue this transaction as its number one priority.
Hydroslotter/Grimes: Biogenerics Limited continues to build on its business relationship with Hydroslotter Corp. There have been some challenges with well No. 2 (Ophelia). Hydroslotter confirms the issues are unrelated to the Hydroslotting technology. It is expected Ophelia will return to its normal flow rates once the issues are resolved. Andreotti No. 1 is still producing at its normal flow rates. Biogenerics looks forward to a continued working relationship with Hydroslotter as opportunities continue to present themselves.
Website: http:/www.bignltd.com
About Biogenerics Limited
Biogenerics is a diversified investment venture capital firm focused on exploiting and distributing domestic oil and gas reserves. Biogenerics also has joint venture activities with Tyche Energy Inc. and Hydroslotter Corp.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this release that are forward-looking statements are based on current expectations and assumptions that are subject to known and unknown risks, uncertainties, or other factors which may cause actual results, performance, or achievements of the company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Actual results could differ materially because of factors such as the effect of general economic and market conditions, entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, technological shifts, and delays in product development and related product release schedules, any of which may cause revenues and income to fall short of anticipated levels. All information in this release is as of the date of this release. The company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company's expectations.
CONTACT: Biogenerics Limited James Lancaster, CEO Corporate Inquiries: (903)-561-2446 Investor Relations: www.bignltd.com
-------------------- "No nation was ever ruined by trade." Benjamin Franklin Posts: 533 | From: Dooville, Indiana | Registered: Jul 2006
| IP: Logged |
posted
this is great news, alot more production and acqisition than once anticipated. i wish i hadn't sold off half of my position * .019 on that last run! I might buy more again.
Posts: 292 | Registered: Mar 2006
| IP: Logged |
posted
Just loaded up some more today at .014, this is going to get very interesting indeed.
Posts: 201 | From: Cornwall | Registered: Feb 2006
| IP: Logged |
posted
Big fakey paint at .012 for a sell,a few shares * EOD friday. Traded all day between .014 and .015. Ask is at .016. Tuesday will be big(N) IMO
Posts: 292 | Registered: Mar 2006
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Smile]](smile.gif)
![[Big Grin]](biggrin.gif)
![[Cool]](cool.gif)
